SCHEMBL23660971

SCHEMBL23660971

FC(F)(F)C(=C(N1CCC(C(F)(F)F)CC1)C(F)(F)C(F)(F)F)C(F)(F)F

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.30
SPR P35270 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23661364 0.88 NAMPT (0.33) NAMPTSPR
SCHEMBL17453101 0.80 NAMPT (0.34) NAMPTSPR
SCHEMBL23661367 0.77 MLYCD (0.33)
SCHEMBL23660968 0.75 MLYCD (0.33)
SCHEMBL23661365 0.75 MLYCD (0.33)
SCHEMBL23661363 0.72 MLYCD (0.36)
SCHEMBL2487675 0.69
SCHEMBL25698959 0.69 SPR (0.33) NAMPTSPR
SCHEMBL27872557 0.69 HRH3 (0.47) NAMPTSPR
SCHEMBL17453119 0.68 NAMPT (0.31) NAMPTSPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210221776-A1 PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210221776-A1 PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME FGB, RFTN1, AFF1 NAMPT 4815/4885SPR 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.